Related Experiment Video

Updated: May 13, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Boosting immunity to small tumor-associated carbohydrates with bacteriophage qβ capsids

Zhaojun Yin1, Marta Comellas-Aragones, Sudipa Chowdhury

  • 1Department of Chemistry, Chemistry Building, Room 426, 578 South Shaw Lane, Michigan State University , East Lansing, Michigan 48824, United States.

ACS Chemical Biology
|March 20, 2013
PubMed

Insights

Developing a cancer vaccine using bacteriophage Qβ virus-like particles effectively targets tumor-associated carbohydrate antigens (TACAs). This approach overcomes the poor immunogenicity of carbohydrates, showing promise for effective immunotherapy.

Area of Science:

  • Immunology
  • Oncology
  • Vaccine Development

Background:

  • Cancer immunotherapy seeks effective strategies targeting tumor-associated carbohydrate antigens (TACAs).
  • TACAs are overexpressed on cancer cells but are often poorly immunogenic, limiting their use in vaccines.
  • Developing vaccines against weak TACAs like the Tn antigen presents a significant challenge.

Purpose of the Study:

  • To investigate the potential of bacteriophage Qβ virus-like particles (VLPs) as a platform for developing anticancer vaccines.
  • To evaluate the immunogenicity of displaying the Tn antigen on Qβ VLPs.
  • To determine factors influencing the antibody response, including adjuvants, antigen display, and dose.

Main Methods:

  • Displaying the Tn antigen on bacteriophage Qβ VLPs.
  • Administering vaccines with varying adjuvants, antigen display patterns, and doses.
  • Analyzing antibody responses, including IgG titers and subclasses.
  • Utilizing glycan microarray analysis to assess antibody specificity.
  • Testing antibody reactivity against native Tn antigens on human leukemia cells.

Main Results:

  • Displaying the Tn antigen on Qβ VLPs elicited potent humoral immune responses.
  • High local antigen density, not total antigen amount, was critical for inducing strong Tn-specific IgG titers.
  • Antibodies generated showed high selectivity for Tn antigens.
  • Qβ VLPs induced significantly higher IgG levels compared to other VLPs.
  • The produced antibodies effectively recognized native Tn antigens on leukemia cells.

Conclusions:

  • Bacteriophage Qβ VLPs are a highly promising platform for carbohydrate-based anticancer vaccines.
  • The Qβ platform effectively overcomes the poor immunogenicity of TACAs like the Tn antigen.
  • This approach offers a viable strategy for developing targeted immunotherapies against various cancers expressing TACAs.

More Related Videos

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Making Conjugation-induced Fluorescent PEGylated Virus-like Particles by Dibromomaleimide-disulfide Chemistry10:18

Making Conjugation-induced Fluorescent PEGylated Virus-like Particles by Dibromomaleimide-disulfide Chemistry

Published on: May 27, 2018

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...